CD19 and neoplasm: The substantially higher number of transduced cells in blood upon GFP delivery cannot only be explained by the higher vector potency due to the smaller size of GFP compared to CD19‐CAR,[36] CAR T cells migrate into tumor locations, in this case, the bone marrow, resulting in underestimated values of transduced cells in peripheral blood.